International Biotechnology (LON:IBT) Stock Crosses Above 200-Day Moving Average – Should You Sell?

International Biotechnology (LON:IBT) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 940.46 and traded as high as GBX 992. International Biotechnology shares last traded at GBX 992, with a volume of 32,148 shares changing hands.

International Biotechnology Price Performance

The company’s fifty day moving average is GBX 950.98 and its 200 day moving average is GBX 941.69. The company has a quick ratio of 0.32, a current ratio of 0.11 and a debt-to-equity ratio of 9.43. The stock has a market cap of £314.46 million, a PE ratio of -300.30 and a beta of 0.32.

International Biotechnology (LON:IBT) last posted its quarterly earnings results on Tuesday, May 12th. The company reported GBX (4.83) EPS for the quarter. International Biotechnology had a net margin of 82.27% and a return on equity of 27.35%. The business had revenue of GBX 24 million during the quarter. As a group, sell-side analysts anticipate that International Biotechnology will post 0.9435943 earnings per share for the current fiscal year.

About International Biotechnology

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.

The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.